CZ287795A3 - The use of a peptide derivative, combination of derivatives and pharmaceutical preparation - Google Patents

The use of a peptide derivative, combination of derivatives and pharmaceutical preparation Download PDF

Info

Publication number
CZ287795A3
CZ287795A3 CZ952877A CZ287795A CZ287795A3 CZ 287795 A3 CZ287795 A3 CZ 287795A3 CZ 952877 A CZ952877 A CZ 952877A CZ 287795 A CZ287795 A CZ 287795A CZ 287795 A3 CZ287795 A3 CZ 287795A3
Authority
CZ
Czechia
Prior art keywords
ethyl
methyl
cme
dimethylpropyl
tbg
Prior art date
Application number
CZ952877A
Other languages
Czech (cs)
English (en)
Inventor
James Gus Chafouleas
Robert Deziel
Original Assignee
Bio Mega Boehringer Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Mega Boehringer Ingelheim filed Critical Bio Mega Boehringer Ingelheim
Publication of CZ287795A3 publication Critical patent/CZ287795A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CZ952877A 1993-05-03 1994-04-29 The use of a peptide derivative, combination of derivatives and pharmaceutical preparation CZ287795A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002095408A CA2095408A1 (en) 1993-05-03 1993-05-03 Method of combating acyclovir-resistant herpes simplex viral infections

Publications (1)

Publication Number Publication Date
CZ287795A3 true CZ287795A3 (en) 1996-06-12

Family

ID=4151571

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ952877A CZ287795A3 (en) 1993-05-03 1994-04-29 The use of a peptide derivative, combination of derivatives and pharmaceutical preparation

Country Status (13)

Country Link
EP (1) EP0767671A1 (no)
JP (1) JPH08509476A (no)
KR (1) KR960701651A (no)
CN (1) CN1126438A (no)
AU (1) AU683465B2 (no)
BR (1) BR9406575A (no)
CA (1) CA2095408A1 (no)
CZ (1) CZ287795A3 (no)
HU (1) HUT73779A (no)
NO (1) NO954390L (no)
SG (1) SG48806A1 (no)
SK (1) SK132695A3 (no)
WO (1) WO1994025046A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817638A (en) * 1988-07-07 1998-10-06 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6252060B1 (en) 1988-07-07 2001-06-26 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
CA2139169C (en) * 1994-12-28 2001-05-01 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes peptidomimetic compounds
CN109627243B (zh) * 2019-01-09 2021-06-29 广西壮族自治区水产科学研究院 一种喷昔洛韦-铜配合物、合成方法及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2033448C (en) * 1990-12-31 1996-11-26 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes compositions and method of use
SG42995A1 (en) * 1992-03-12 1997-10-17 Bio Mega Boehringer Ingelheim Isosteric antiherpes peptide derivatives

Also Published As

Publication number Publication date
HUT73779A (en) 1996-09-30
CA2095408A1 (en) 1994-11-04
SG48806A1 (en) 1998-05-18
CN1126438A (zh) 1996-07-10
NO954390D0 (no) 1995-11-02
KR960701651A (ko) 1996-03-28
AU6642394A (en) 1994-11-21
WO1994025046A1 (en) 1994-11-10
SK132695A3 (en) 1996-10-02
AU683465B2 (en) 1997-11-13
EP0767671A1 (en) 1997-04-16
BR9406575A (pt) 1996-03-19
HU9503135D0 (en) 1996-01-29
JPH08509476A (ja) 1996-10-08
NO954390L (no) 1996-01-02

Similar Documents

Publication Publication Date Title
US5484771A (en) Antiherpes peptide derivatives having a 1,4-dioxo-C, N-terminus
JP3209553B2 (ja) ヘルペス感染治療用医薬組成物
CZ287795A3 (en) The use of a peptide derivative, combination of derivatives and pharmaceutical preparation
EP0560267B1 (en) Isosteric antiherpes peptide derivatives
JPH04275229A (ja) ヘルペス感染治療用医薬組成物
AU683450B2 (en) Inhibitors of herpes viral ribonucleotide reductase
US5574015A (en) Isosteric antiherpes peptide derivatives
US5830864A (en) Antiherpes peptide derivatives having a ureido n-terminus
EP0560274B1 (en) Antiherpes peptide derivatives having a ureido N-terminus
AU671825C (en) Isosteric antiherpes peptide derivatives
US5846941A (en) Isosteric antiherpes peptide derivatives II
JP3613818B2 (ja) トリコポリン誘導体